Quantumup
Posted - 2 days ago
BTIGβ¬οΈPT $PTGX $67 was $51/Buy, after ascribingπ³to PN-881 based on the implied EV of $DICE's ACQ by $LLY, (on only P1 data), risk adj'd by 50%. BTIG thinks PN-881's differentiated specificity could support preferential positioning as the dominant oral IL-17 inhibitor: $ucbjy $nvs
JoeBeets007
Posted - 2 months ago
$DICE uh oh
NVDAMillionaire
Posted - 3 months ago
$DICE DICE Therapeutics, Inc. (NASDAQ:DICE): A Promising Biopharmaceutical Company Poised for Growth http://beyondspx.com/2024/08/04/dice-therapeutics-inc-nasdaqdice-a-promising-biopharmaceutical-company-poised-for-growth/
valueforme
Posted - 3 months ago
$PRQR By "like these" he meant $DICE and $MORF deals, early ish stage assets, novel science.
stockilluminati
Posted - 1 year ago
$DICE https://clinicaltrials.gov/study/NCT05994807 - trial update posted here!
tickeron
Posted - 1 year ago
$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4856108
tickeron
Posted - 1 year ago
$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4852991
tickeron
Posted - 08/29/23
$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4847705
tickeron
Posted - 08/27/23
$ATOM vs. $DICE: which stock is the best to buy? #Atomera https://srnk.us/go/4846224
tickeron
Posted - 1 year ago
$BR vs. $DICE: what is the best stock to add to your portfolio? #BroadridgeFinancialSolutions https://srnk.us/go/4841749
tickeron
Posted - 1 year ago
$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4840908
cctranscripts
Posted - 1 year ago
Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12473852 $DICE
Quantisnow
Posted - 1 year ago
$DICE π SEC Form 15-12G filed by DICE Therapeutics Inc.
https://quantisnow.com/i/4920041?utm_source=stocktwits
45 seconds delayed.
tickeron
Posted - 1 year ago
$ATOM vs. $DICE: what is the best stock to add to your portfolio? #Atomera https://srnk.us/go/4839035
macroaxis
Posted - 1 year ago
$NERV - Investment perspective on Minerva Neurosciences vs. Dice Molecules ( $DICE ) in September 2023. Next fiscal quarter end is on 30th of September 2023 https://www.macroaxis.com/competition/NERV/DICE/Minerva-vs-Dice #portfolio_prospective #better_portfolio #diversify
ChartMill
Posted - 1 year ago
$NVO, $DICE and $BLDR. Strong technicals stocks and near a new high.
https://www.chartmill.com/stock/stock-screener?sid=16&f=p_pg10,v1_50b500,s_str,s_nnh,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=720&cl=F&o1=3&o2=3&o3=1&op1=200,16711680&op2=50,255&utm_source=Strong_Stocks_near_New_High&utm_medium=stocktwits&utm_campaign=screen
stockilluminati
Posted - 1 year ago
$DICE https://www.stockilluminati.com/dice/filings.php - DICE Therapeutics, Inc. - Common Stock files form EFFECT today, check out the details.
Quantisnow
Posted - 1 year ago
$DICE π SEC Form EFFECT filed by DICE Therapeutics Inc.
https://quantisnow.com/i/4881344?utm_source=stocktwits
45 seconds delayed.
stockilluminati
Posted - 1 year ago
$DICE DICE is scheduled to release earnings after close with EPS estimate -0.661900 and revenue estimate $0 check https://stockilluminati.com/earnings.html
MarketBeat
Posted - 1 year ago
DICE Therapeutics's neutral rating reiterated at HC Wainwright. $48.00 PT. www.marketbeat.com/stocks/NASDAQ/DICE/price-target/ $DICE
cctranscripts
Posted - 1 year ago
RA Capital Healthcare Fund, L.P. just issued a filing suggesting it has sold all of its DICE Th https://www.conferencecalltranscripts.org/summary/?id=12439079 $DICE
Quantisnow
Posted - 1 year ago
$DICE New live insights:
1. π SEC Form SC 13D/A filed by DICE Therapeutics Inc. (Amendment)
https://quantisnow.com/i/4872367?utm_source=stocktwits
2. π SEC Form 4 filed by Ra Capital Management, L.P.
https://quantisnow.com/i/4872377?utm_source=stocktwits
#healthcare
Quantisnow
Posted - 1 year ago
$DICE New insights just appeared:
1. π SEC Form 4: Scheller Richard H returned 8,427 shares to the company, closing all direct ownership in the company
https://quantisnow.com/i/4871751?utm_source=stocktwits
2. π SEC Form 4: Robertson Scott M. returned 198,000 shares to the company, closing all direct ownership in the company
https://quantisnow.com/i/4871866?utm_source=stocktwits
3. π SEC Form 4: Scopa James Paul returned 40,921 shares to the company, closing all direct ownership in the company
https://quantisnow.com/i/4871907?utm_source=stocktwits
4. π SEC Form 4 filed by Simson Jake
https://quantisnow.com/i/4871963?utm_source=stocktwits
5. π SEC Form 4: Tetlow Sharon returned 49,841 shares to the company, closing all direct ownership in the company
https://quantisnow.com/i/4871997?utm_source=stocktwits
#healthcare
Quantisnow
Posted - 1 year ago
$DICE π SEC Form 4: Timothy Lu returned 152,285 shares to the company, closing all direct ownership in the company
https://quantisnow.com/i/4871715?utm_source=stocktwits
45 seconds delayed.
Quantisnow
Posted - 1 year ago
$DICE π SEC Form 4 filed by Bowers Lisa
https://quantisnow.com/i/4871531?utm_source=stocktwits
45 seconds delayed.
risenhoover
Posted - 1 year ago
$DICE / DICE Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 DICE THERAPEUTICS, https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing